| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 3
Topical apigenin as a promising therapeutic agent for psoriasis: Evaluating efficacy alone and in combination with clobetasol in an imiquimod-induced model of psoriasis in mice
1 Al-Nahrain University, College of Medicine, Department of Pharmacology, Baghdad, IraqDOI : 10.23893/1307-2080.APS6239 Viewed : 1956 - Downloaded : 201 Keywords :